Eleftheria E. Kampouri

Lausanne, VD, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 42 publications

Cytomegalovirus-Cell-Mediated Immunity Assays for the Prevention and Management of Cytomegalovirus in Transplant Recipients and Patients Receiving Cellular Therapies.

Cytomegalovirus-Cell-Mediated Immunity Assays for the Prevention and Management of Cytomegalovirus in Transplant Recipients and Patients Receiving Cellular Therapies.

Journal: Transplant infectious disease : an official journal of the Transplantation Society

Published: April 16, 2026

Infectious risk associated with new biological therapies : an update

Infectious risk associated with new biological therapies : an update

Journal: Revue medicale suisse

Published: April 10, 2026

Case Report: Transverse myelitis following CAR-T cell therapy for post-transplant lymphoproliferative disorder.

Case Report: Transverse myelitis following CAR-T cell therapy for post-transplant lymphoproliferative disorder.

Journal: Frontiers in immunology

Published: January 23, 2026

The changing epidemiology of invasive mould diseases in immunosuppressed patients: what, why, how?

The changing epidemiology of invasive mould diseases in immunosuppressed patients: what, why, how?

Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases

Published: August 01, 2025

Immunodeficiencies in Adults: Key Considerations for Diagnosis and Management.

Immunodeficiencies in Adults: Key Considerations for Diagnosis and Management.

Journal: Clinical reviews in allergy & immunology

Published: July 11, 2025

American Society for Transplantation and Cellular Therapy Series #9: Management of Human Herpesvirus 6B After Hematopoietic Cell Transplantation and Chimeric Antigen Receptor-T-Cell Therapy.

American Society for Transplantation and Cellular Therapy Series #9: Management of Human Herpesvirus 6B After Hematopoietic Cell Transplantation and Chimeric Antigen Receptor-T-Cell Therapy.

Journal: Transplantation and cellular therapy

Published: May 05, 2025

Q Fever: what's new?

Q Fever: what's new?

Journal: Revue medicale suisse

Published: April 10, 2025

Nocardiosis in solid organ transplant recipients: Clinical challenges

Nocardiosis in solid organ transplant recipients: Clinical challenges

Journal: Revue medicale suisse

Published: April 10, 2025

Can Quantitative Polymerase Chain Reaction in Tissue Improve Cytomegalovirus Management? Balancing Diagnostic Sensitivity and the Risk of Overtreatment.

Can Quantitative Polymerase Chain Reaction in Tissue Improve Cytomegalovirus Management? Balancing Diagnostic Sensitivity and the Risk of Overtreatment.

Journal: Transplant infectious disease : an official journal of the Transplantation Society

Published: April 07, 2025

ELISPOT as a predictor of clinically significant cytomegalovirus infection after hematopoietic cell transplantation in letermovir recipients.

ELISPOT as a predictor of clinically significant cytomegalovirus infection after hematopoietic cell transplantation in letermovir recipients.

Journal: Bone marrow transplantation

Published: February 04, 2025

The impact of CMV reactivation on mortality after chimeric antigen receptor T-cell therapy.

The impact of CMV reactivation on mortality after chimeric antigen receptor T-cell therapy.

Journal: Blood advances

Published: December 10, 2024

Chimeric antigen receptor-T-cell therapies going viral: latent and incidental viral infections.

Chimeric antigen receptor-T-cell therapies going viral: latent and incidental viral infections.

Journal: Current opinion in infectious diseases

Published: October 03, 2024

Showing 1-12 of 42

Last Updated: 09/26/2026